Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.48M | $4.23M | $4.60M | $3.09M | $2.20M | $0.00 | $1.50M | $370K | $109K | $144K |
| Revenue growth | — | 185.2% | 8.8% | -32.8% | -29.0% | -100.0% | — | -75.3% | -70.5% | 32.1% |
| Operating income | -$38.6M | -$38.6M | -$35.3M | -$27.3M | -$21.5M | -$16.8M | -$11.5M | -$17.7M | -$15.1M | -$12.6M |
| Operating margin | -2605.7% | -911.9% | -766.3% | -882.4% | -977.9% | — | -765.3% | -4792.2% | -13840.4% | -8761.1% |
| Net income | -$38.6M | -$38.4M | -$34.8M | -$26.6M | -$18.7M | -$16.8M | -$11.4M | -$17.3M | -$14.7M | -$2.49M |
| Net margin | -2601.1% | -908.9% | -756.1% | -861.7% | -852.0% | — | -763.2% | -4664.6% | -13459.6% | -1727.8% |
| EPS (diluted) | -$0.43 | -$0.39 | -$0.32 | -$0.23 | -$2.80 | -$2.44 | -$1.32 | -$1.98 | -$19.25 | -$1.70 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$29.4M | -$29.2M | -$28.9M | -$20.4M | -$14.9M | -$13.3M | -$8.45M | -$12.4M | -$14.7M | -$9.46M |
| Capital expenditures | $2.11M | $1.35M | $226K | $79.0K | $0.00 | $405K | $409K | $396K | $42.0K | $13.0K |
| Free cash flow | -$31.5M | -$30.5M | -$29.1M | -$20.5M | -$14.9M | -$13.7M | -$8.86M | -$12.8M | -$14.7M | -$9.47M |
| Share buybacks | — | — | — | — | $0.00 | $1.00K | $0.00 | — | — | — |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $62.1M | $62.8M | $43.7M | $36.5M | $27.4M | $37.4M | $28.7M | $15.3M | $2.90M | $11.3M |
| Total assets | $67.6M | $69.2M | $49.8M | $40.6M | $28.4M | $39.9M | $33.3M | $20.3M | $6.35M | $14.7M |
| Total liabilities | $5.39M | $6.82M | $5.24M | $4.33M | $1.81M | $721K | $3.09M | $4.98M | $2.75M | $4.16M |
| Shareholders' equity | $62.2M | $62.4M | $44.6M | $36.3M | $26.6M | $39.2M | $30.2M | $15.3M | $3.60M | $10.5M |
| Retained earnings | -$161M | -$199M | -$234M | -$261M | -$279M | -$296M | -$308M | -$325M | -$340M | -$342M |
| Shares (wtd avg diluted) | 92.4M | 105M | 111M | 124M | 6.53M | 8.67M | 8.70M | 8.71M | 762K | 1.46M |
Every figure is extracted from VivoSim Labs, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.